On-Demand Webcast

Share

Program Content

Activities

  • HER2-Positive Advanced GI Cancers
    HER2-Positive Advanced Gastrointestinal Cancers: Expert Guidance on Leveraging Targeted Agents to Improve Outcomes
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 21, 2023

    Expires: June 20, 2024

Faculty

cover img faculity

Geoffrey Ku, MD

Associate Attending Physician
Head, Esophagogastric Section, Gastrointestinal Oncology Service & member, Cellular Therapy Service
Department of Medicine

cover img faculity

Kanwal Raghav, MD

Associate Professor
Gastrointestinal Medical Oncology
The University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Zev A. Wainberg, MD

Professor of Medicine and Surgery
Co-Director, GI Oncology
Director, Early Phase Clinical Research Program
Jonsson Comprehensive Cancer Center
UCLA School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Inc., and Seagen Inc.

AstraZeneca

Daiichi Sankyo, Inc.

Seagen Inc.